enVVeno Medical Corporation NVNO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -11.84% | -18.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.55% | -6.58% | |||
| Operating Income | 6.55% | 6.58% | |||
| Income Before Tax | 6.47% | -3.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 6.47% | -3.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 6.47% | -3.02% | |||
| EBIT | 6.55% | 6.58% | |||
| EBITDA | 6.60% | 6.62% | |||
| EPS Basic | 8.84% | 2.77% | |||
| Normalized Basic EPS | 8.64% | 10.18% | |||
| EPS Diluted | 8.84% | 2.77% | |||
| Normalized Diluted EPS | 8.64% | 10.18% | |||
| Average Basic Shares Outstanding | 2.60% | 5.96% | |||
| Average Diluted Shares Outstanding | 2.60% | 5.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||